loading
Schlusskurs vom Vortag:
$4.76
Offen:
$4.78
24-Stunden-Volumen:
92,801
Relative Volume:
1.34
Marktkapitalisierung:
$52.19M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00135
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+3.02%
1M Leistung:
+32.04%
6M Leistung:
-42.62%
1J Leistung:
-63.79%
1-Tages-Spanne:
Value
$4.55
$4.85
1-Wochen-Bereich:
Value
$4.50
$5.02
52-Wochen-Spanne:
Value
$3.39
$16.00

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Name
Firmenname
Avalo Therapeutics Inc
Name
Telefon
410-522-8707
Name
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
Mitarbeiter
23
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AVTX's Discussions on Twitter

Vergleichen Sie AVTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AVTX
Avalo Therapeutics Inc
4.78 52.19M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt H.C. Wainwright Buy
2025-03-25 Eingeleitet Jefferies Buy
2025-03-25 Eingeleitet Stifel Buy
2025-02-28 Eingeleitet Piper Sandler Overweight
2025-02-21 Eingeleitet Wedbush Outperform
2024-12-19 Eingeleitet BTIG Research Buy
2024-10-24 Eingeleitet H.C. Wainwright Neutral
2024-04-16 Hochstufung Oppenheimer Perform → Outperform
2021-09-24 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten

pulisher
Jun 18, 2025

(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com

Jun 18, 2025
pulisher
Jun 15, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

AVTX Virtual Meeting Scheduled for June 23 by BTIG | AVTX Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 11, 2025

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) PT at $30.00 - Defense World

Jun 11, 2025
pulisher
Jun 05, 2025

Avalo Therapeutics Signs New Sales Agreement - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

AVTX: Avalo Therapeutics Receives Buy Rating with $15 Target Pri - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics (AVTX) Receives Buy Rating from H.C. Wainwright | AVTX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cardax (OTCMKTS:CDXI) and Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Analysis - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World

May 31, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferenc - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 27, 2025
pulisher
May 17, 2025

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Bought by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 13, 2025

Strong Cash Position Secures AVTX Through 2027 | AVTX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Avalo Therapeutics Reports Improved Financial Performance - TipRanks

May 13, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics reports Q1 EPS ($1.25) vs. ($141.14) last year - TipRanks

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

AVTX Advances Phase 2 LOTUS Trial, Targets 2026 Data | AVTX Stoc - GuruFocus

May 12, 2025
pulisher
May 12, 2025

AVALO THERAPEUTICS Earnings Results: $AVTX Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Bu - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Announces Leadership Change and Updates on AVTX-009 Phase 2 Trial for Hidradenitis Suppurativa - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire Inc.

May 12, 2025
pulisher
May 10, 2025

Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 08, 2025

Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks

May 08, 2025
pulisher
May 07, 2025

15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World

May 07, 2025
pulisher
May 06, 2025

When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com

May 06, 2025
pulisher
May 06, 2025

Avalo Therapeutics Enters $75 Million Sales Agreement With TD Cowen For Common Stock Offering - marketscreener.com

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025
pulisher
Apr 23, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World

Apr 22, 2025
pulisher
Apr 22, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World

Apr 22, 2025
pulisher
Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Seven new option listings and one option delisting on April 16th - TipRanks

Apr 16, 2025
pulisher
Apr 15, 2025

Avalo Therapeutics Reports 2024 Financial Results - TipRanks

Apr 15, 2025
pulisher
Apr 09, 2025

Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com

Apr 09, 2025
pulisher
Apr 04, 2025

(AVTX) On The My Stocks Page - news.stocktradersdaily.com

Apr 04, 2025

Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Avalo Therapeutics Inc-Aktie (AVTX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Almenoff June Sherie
Director
Nov 12 '24
Buy
12.50
500
6,250
500
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):